17.38
price up icon3.15%   0.53
pre-market  시장 영업 전:  17.21   -0.17   -0.98%
loading

Celldex Therapeutics Inc (CLDX) 재무 분석

손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
기간 종료일 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
기간 3개월 3개월 3개월 3개월 3개월
Revenues
96.22%
0.156
4.131 1.517 0.268 0.967
Operating Expenses
20.78%
40.76
51.46 42.76 33.47 33.44
Benefits Costs and Expenses
5.48%
40.76
38.65 42.76 33.47 33.44
Costs And Expenses
21.24%
40.76
51.76 42.76 33.47 33.44
Operating Income/Loss
14.74%
-40.61
-47.63 -41.24 -33.20 -32.47
Income/Loss From Continuing Operations Before Tax
17.66%
-40.61
-34.51 -41.24 -30.50 -29.36
Income/Loss From Continuing Operations After Tax
353.21%
-32.81
-7.239 -38.26 -30.50 -29.36
Net Income/Loss
24.24%
-32.81
-43.31 -38.26 -30.50 -29.36
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
4,782%
0.0589
0.00121 0.0473 0.0473 0.0472
Diluted Average Shares
4,782%
0.0589
0.00121 0.0473 0.0473 0.0472
Basic Earnings Per Share
33.33%
-0.56
-0.84 -0.81 -0.65 -0.62
Diluted Earnings Per Share
33.33%
-0.56
-0.84 -0.81 -0.65 -0.62
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$73.44
price up icon 2.00%
$68.32
price up icon 0.56%
$31.28
price up icon 0.35%
$20.46
price up icon 8.83%
$93.32
price up icon 3.36%
biotechnology ONC
$274.78
price up icon 1.38%
자본화:     |  볼륨(24시간):